Skip to main content
Glama

Assay Systems procurement register

Awards won without a rival

assay_solo
Read-onlyIdempotent

Buyer × supplier pairs where the supplier won without a rival, locks and buyer shares; without country — the list of countries. Paid: USD 0.01 per call in USDC on Base via x402 (or an X-API-Key Commercial key on the MCP request).

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
kindNo
pageNoPage of the result list (default 1).
buyerNoWords of the buyer's name.
countryNoTwo-letter country code in lower case, e.g. ca, us, gb, ua. assay_countries lists them.
supplierNoWords of the supplier's name.

Schema Changelog

Changes observed during successful MCP inspections.

  1. First observed

TDQS

B3.2/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint=true, idempotentHint=true and openWorldHint=false, so the safety profile is covered. The description adds genuinely non-structured context: the call is paid at USD 0.01 in USDC on Base via x402, or authenticated with an X-API-Key Commercial key. That payment/auth disclosure is real value beyond the annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness3/5

Is the description appropriately sized, front-loaded, and free of redundancy?

It is short, but the single packed sentence is grammatically fractured and forces re-reading; the kind-mapping content is front-loaded but the phrasing is not clean enough to earn a 4.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness3/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description must carry the return-shape burden, and it only partly does: the kind→output mapping helps, but pagination behaviour, result format and the semantics of the optional buyer/supplier filters are left to the schema. Adequate but with clear gaps.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 80%, so the baseline is 3, but the description goes further by mapping the `kind` enum values to outputs (pairs, locks, buyers) and explaining the `country` behaviour (omitting it yields the country list). This adds meaning the schema alone does not carry.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose3/5

Does the description clearly state what the tool does and how it differs from similar tools?

The title and description identify the resource (buyer×supplier pairs where a supplier won uncontested) but the body sentence is jargon-heavy and syntactically broken ('locks and buyer shares; without country — the list of countries'), so the exact scope is hard to pin down. It never names the sibling it is not, and 'won without a rival' reads nearly identically to the sibling assay_uncontested, leaving the boundary ambiguous.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines2/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

There is no explicit when-to-use guidance and no reference to any of the ten sibling tools, even the obviously overlapping assay_uncontested. The agent is left to infer selection from the name alone.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

Resources